Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Clinical trial NCT06632977 · RECRUITING

Trial details

NCT number: NCT06632977
Sponsor: Alliance for Clinical Trials in Oncology
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Castration-Resistant Prostate Carcinoma Stage IVB Prostate Cancer AJCC v8

Start date: 2025-02-06
Primary completion: 2030-04-11
Enrollment: 474

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.